SUBSTITUTIONS AT THE P2' SITE OF GAG P17-P24 AFFECT CLEAVAGE EFFICIENCY BY HIV-1 PROTEASE

被引:39
|
作者
MARGOLIN, N [1 ]
HEATH, W [1 ]
OSBORNE, E [1 ]
LAI, M [1 ]
VLAHOS, C [1 ]
机构
[1] ELI LILLY INT CORP,LILLY RES LAB,BIOCHEM RES,INDIANAPOLIS,IN 46285
关键词
D O I
10.1016/0006-291X(90)92060-D
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heptapeptide substrates containing a single amino acid substitution at the p2′ position of the gag p17-p24 junction (S-Q-N-Y-P-X-V where X = G, A, L, I, F, and W) were compared as substrates for HIV-1 protease. Binding of the Ile-, Leu-, and Ala- containing peptides was about equal although hydrolysis was 20-fold lower for the Ala and Leu peptides compared to Ile. Insertion of Gly or Phe at the p2′ position resulted in significantly lower cleavage of the peptide while a Trp-containing peptide was not cleaved. These data suggest that a relatively small hydrophobic amino acid is important for hydrolysis and binding at this site. Structure-activity studies such as those described here may be useful in the design of specific inhibitors for HIV-1 protease. © 1990.
引用
收藏
页码:554 / 560
页数:7
相关论文
共 50 条
  • [1] Flexibility in the P2 domain of the HIV-1 Gag polyprotein
    Newman, JL
    Butcher, EW
    Patel, DT
    Mikhaylenko, Y
    Summers, MF
    PROTEIN SCIENCE, 2004, 13 (08) : 2101 - 2107
  • [2] THE GAG PRECURSOR CONTAINS A SPECIFIC HIV-1 PROTEASE CLEAVAGE SITE BETWEEN THE NC (P7) AND P1 PROTEINS
    WONDRAK, EM
    LOUIS, JM
    DEROCQUIGNY, H
    CHERMANN, JC
    ROQUES, BP
    FEBS LETTERS, 1993, 333 (1-2) : 21 - 24
  • [3] Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2′ to P1/P1′
    Ax, A
    Schaal, W
    Vrang, L
    Samuelsson, B
    Hallberg, A
    Karlén, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (03) : 755 - 764
  • [4] NOVEL INHIBITORS OF HIV-1 PROTEASE CONTAINING AN ISOPHTHALIC CARBOXAMIDE AT THE P2 SITE
    KALDOR, SW
    DRESSMAN, BA
    HAMMOND, M
    APPELT, K
    SU, KS
    CAMPANALE, KM
    BURGESS, JA
    LUBBENHUSEN, PP
    BAXTER, AJ
    MUESING, MA
    HATCH, SD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 122 - MEDI
  • [5] Functionalized aliphatic P2/P2' analogs of HIV-1 protease inhibitor DMP323
    Smallheer, JM
    McHugh, RJ
    Chang, CH
    Kaltenbach, RF
    Worley, TV
    Klabe, RM
    Bacheler, LT
    Rayner, MM
    EricksonViitanen, S
    Seitz, SP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (11) : 1365 - 1370
  • [6] Crystal structure of chemically synthesized HIV-1 protease and a ketomethylene isostere inhibitor based on the p2/NC cleavage site
    Torbeev, Vladimir Yu.
    Mandal, Kalyaneswar
    Terechko, Valentina A.
    Kent, Stephen B. H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (16) : 4554 - 4557
  • [7] Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2' substituents
    Patel, M
    Rodgers, JD
    McHugh, RJ
    Johnson, BL
    Cordova, BC
    Klabe, RM
    Bacheler, LT
    Erickson-Viitanen, S
    Ko, SS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (22) : 3217 - 3220
  • [8] Calmodulin binds HIV-1 gag and p17
    Radding, W
    Williams, JP
    McKenna, MA
    Hunter, E
    Tytler, EM
    McDonald, JM
    BIOPHYSICAL JOURNAL, 1997, 72 (02) : TUPM1 - TUPM1
  • [9] P17-14. Fitness-informed HIV-1 Gag-p24 vaccine design
    MM Rolland
    VJ Swain
    E Lanxon-Cookson
    U Rao
    KR Henry
    EJ Arts
    DC Nickle
    JI Mullins
    Retrovirology, 6
  • [10] Placement of p6pol between tandem repeat HIV-1 protease domains reduces Gag cleavage efficiency
    Chou, Tin-An
    Huang, Kuo-Jung
    Wang, Chin-Tien
    RETROVIROLOGY, 2013, 10 : S34 - S34